Manuscripts

Search by keyword, year, or author name.

Showing 1552 manuscripts.

Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests

J. Robins, Dianne M. Finkelstein. Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics. 2000. 56: 779-88.

Year

2000

Journal

Biometrics

Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks

Charles Raines, Charles Flexner, Eugene Sun, Margo E. Heath-Chiozzi, Ronald Lewis, Catherine Fields, C. Deetz, Linda Apuzzo, Susan H. Eshleman, Brooks Jackson, Joel E. Gallant. Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks. Journal of Acquired Immune Deficiency Syndromes. 2000. 25: 322-8.

Year

2000

Journal

Journal of Acquired Immune Deficiency Syndromes

Pharmacokinetics of Azithromycin Administered Alone and with Atovaquone in Human Immunodeficiency Virus-Infected Children

Leock Y. Ngo, Ram Yogev, Wayne M. Dankner, Walter T. Hughes, Sandra Burchett, Jing Xu, Brian Sadler, Jashvant D. Unadkat. Pharmacokinetics of Azithromycin Administered Alone and with Atovaquone in Human Immunodeficiency Virus-Infected Children. Antimicrobial Agents and Chemotherapy. 1999. 43: 1516-19.

Year

1999

Journal

Antimicrobial Agents and Chemotherapy

Combination Therapy with Stavudine (d4T) Plus Didanosine (ddI) In Children With Human Immunodeficiency Virus Infection

Mark W. Kline, Russell B. Van Dyke, Jane C. Lindsey, Meg Gwynne, Mary Culnane, Clemente Diaz, Ram Yogev, Ross E. McKinney, Elaine J. Abrams, Lynne M. Mofenson. Combination Therapy with Stavudine (d4T) Plus Didanosine (ddI) In Children With Human Immunodeficiency Virus Infection. Pediatrics. 1999. 103: e62.

Year

1999

Journal

Pediatrics

Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-infected Children: Safety, CD4+ Lymphocyte Count, Viral Load, and Neutrophil Function (AIDS Clinical Trials Group Protocol 211)

William T. Shearer, Mark W. Kline, Stuart L. Abramson, Terence Fenton, Stuart E. Starr, Steven D. Douglas. Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-infected Children: Safety, CD4+ Lymphocyte Count, Viral Load, and Neutrophil Function (AIDS Clinical Trials Group Protocol 211). Clinical and Diagnostic Laboratory Immunology. 1999. 6: 311-15.

Year

1999

Journal

Clinical and Diagnostic Laboratory Immunology

Influence Of Age and Food On Didanosine Pharmacokinetics In HIV Infected Children

Stevens RC, Frenkel LM, Rodman JH. Influence Of Age and Food On Didanosine Pharmacokinetics In HIV Infected Children. Pharmacotherapy. 1999. 19: 487.

Year

1999

Journal

Pharmacotherapy

Effect Of Zidovudine On Perinatal HIV-1 Transmission and Maternal Viral Load (Letter)

Shapiro DE, Sperling RS, Coombs RW. Effect Of Zidovudine On Perinatal HIV-1 Transmission and Maternal Viral Load (Letter). Lancet. 1999. 354: 156.

Year

1999

Journal

Lancet

The Effects of Zidovudine in the Subset of Infants Infected with Human Immunodeficiency Virus Type-1

GD McSherry, David E. Shapiro, RW Coombs, N Mcgrath, LM Frenkel, Britto P, M Culnane, RS Sperling. The Effects of Zidovudine in the Subset of Infants Infected with Human Immunodeficiency Virus Type-1. Journal of Pediatrics. 1999. 134: 717-24.

Year

1999

Journal

Journal of Pediatrics

Pharmacokinetics of Zidovudine in Infants: A Population Analysis Across Studies

Mark Mirochnick, Edmund Capparelli, James Connor. Pharmacokinetics of Zidovudine in Infants: A Population Analysis Across Studies. Clinical Pharmacology & Therapeutics. 1999. 66: 16-24.

Year

1999

Journal

Clinical Pharmacology & Therapeutics